Project Details
Description
A multicenter, open-label, flexible-dose, parallel-group evaluation of the cataractogenic potential of quetiapine fumarate and risperidome in the long-term treatment
| Status | Finished |
|---|---|
| Effective start/end date | 4/19/04 → 12/31/07 |
Funding
- ASTRAZENECA
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.